Biodegradable Advantage Opportunity to engage with hospital procurement and orthopedic surgeons around the adoption of dissolvable composite implants that eliminate metal implants and reduce need for implant removal surgeries, highlighting potential cost savings and improved patient outcomes.

Early Stage Innovator Target early adopters and research institutions for collaboration on clinical trials and regulatory milestones, leveraging patents and the promise of transforming fracture care to accelerate pilot programs and data collection.

Pain Reduction value Position the solution as a means to lower reoperation rates and patient discomfort by avoiding secondary surgeries, appealing to payers, hospital administrators, and surgeons focused on value-based care.

Funding Readiness Explore partnerships with venture-backed orthopedic players and potential grant programs, aligning with a revenue range of one to ten million to scale manufacturing, clinical validation, and regulatory activities.

Strategic Partnerships Leverage existing industry peers of similar scale and focus to identify co-development, distribution, or licensing deals, targeting mid-market to large orthopedic manufacturers for manufacturing capacity and market access.